GlassScriptPhysician profile
Aamer H Jamali
NPI 1659309334
$103,369.31
in general payments reported to CMS, 2019-2025
49 companies · $2,495 in 2025
The $2,495 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $12K · 2021: $12K · 2022: $11K · 2023: $22K · 2024: $20K · 2025: $2,495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Food and Beverage: $8,208 · Travel and Lodging: $7,065 · Education: $18.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29,550.00 |
| Food and Beverage | $8,208.08 |
| Travel and Lodging | $7,064.62 |
| Education | $18.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $78,017.78 | 2019-2024 | Xarelto |
| Portola Pharmaceuticals, LLC | $5,246.81 | 2019-2020 | |
| Medtronic Vascular, INC. | $2,781.74 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $1,995.00 | 2021 | |
| Abbott Laboratories | $1,656.25 | 2019-2025 | Jot Dx, Gallant, Navitor |
| Novartis Pharmaceuticals Corporation | $1,633.85 | 2019-2025 | |
| Boston Scientific Corporation | $1,583.12 | 2019-2025 | Watchman Flx, General - Therapies, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $1,553.57 | 2021-2025 | Corevalve Evolut R, Reveal Linq, Confida |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,128.21 | 2019-2025 | Lifevest |
| Amgen INC. | $992.84 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $906.48 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $803.15 | 2021-2025 | Verquvo, Capvaxive |
| Amarin Pharma, INC. | $622.30 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $612.38 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $576.26 | 2019-2025 | Jardiance |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $494.88 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $382.90 | 2019-2025 | Farxiga, Andexxa |
| Abiomed | $199.99 | 2022-2024 | Impella |
| Novo Nordisk INC | $185.90 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Kiniksa Pharmaceuticals, LTD. | $176.34 | 2022-2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $171.03 | 2022-2025 | Onpattro, Amvuttra |
| Shockwave Medical, INC | $158.71 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kiniksa Pharmaceuticals International, Plc | $130.68 | 2024 | Arcalyst |
| Ge Healthcare | $124.99 | 2021 | |
| Cvrx, INC. | $108.15 | 2024-2025 | Barostim Neo System |
| Biosense Webster, INC. | $100.13 | 2019-2025 | Nuvision Ice Catheter |
| Cardiovascular Systems INC. | $94.49 | 2019 | |
| Kestra Medical Technology Services, INC. | $86.98 | 2023 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $82.65 | 2022-2025 | |
| Arbor Pharmaceuticals, INC. | $77.43 | 2019-2021 | |
| Edwards Lifesciences Corporation | $74.35 | 2019-2025 | Sapien 3 Ultra Resilia |
| Esperion Therapeutics, INC. | $62.26 | 2020-2021 | |
| Resmed Corp | $60.68 | 2022 | |
| Heartflow, INC. | $54.84 | 2022-2025 | |
| Actelion Pharmaceuticals US, INC. | $52.44 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $48.06 | 2023 | Evkeeza, Praluent |
| Baxter Healthcare | $47.55 | 2022 | |
| Irhythm Technologies, INC. | $44.35 | 2019-2024 | Zio Monitor, Zio Xt Patch |
| Biotronik INC. | $36.37 | 2019-2025 | Amvia Edge |
| Kowa Pharmaceuticals America, INC. | $35.15 | 2019 | |
| Gilead Sciences, INC. | $31.28 | 2019 | |
| Braemar Manufacturing, LLC | $30.47 | 2019 | |
| Lundbeck LLC | $23.11 | 2019 | |
| Altathera Pharmaceuticals LLC | $20.76 | 2025 | Sotalol Hydrochloride |
| Vertiflex, INC. | $19.88 | 2019 | |
| Astellas Pharma US INC | $16.85 | 2019 | |
| Impulse Dynamics (USA) INC. | $14.40 | 2024 | Optimizer |
| Tactile Systems Technology INC | $11.52 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aamer Jamali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.